| 货号 | 规格 | 价格 | 上海 | 北京 | 珠海 | 重庆 | 武汉 | 购买数量 |
|---|---|---|---|---|---|---|---|---|
S82327-1mg买3赠1 |
99.70% | ￥170.00 |
8 | - | - | - | - |
|
S82327-2mg买3赠1 |
99.70% | ￥230.00 |
7 | - | - | - | - |
|
S82327-5mg买3赠1 |
99.70% | ￥300.00 |
7 | - | - | - | - |
|
S82327-10mg买3赠1 |
99.70% | ￥420.00 |
5 | - | - | - | - |
|
S82327-25mg促销 |
99.70% | ￥710.00 ￥568.00 |
4 | - | - | - | - |
|
S82327-50mg促销 |
99.70% | ￥1000.00 ￥800.00 |
4 | - | - | - | - |
|
S82327-100mg促销 |
≥99% | ￥1400.00 ￥1120.00 |
货期：2-3天 | - | - | - | - |
|
| 产品描述： | Solcitinib is an orally active, competitive, potent, selective JAK1 inhibitor, with an IC50 of 9.8 nM, and 11-, 55- and 23-fold selectivity over JAK2, JAK3 and TYK2, respectively; Solcitinib is used in the research of moderate-to-severe plaque-type psoriasis. | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 靶点： | JAK1:9.8 nM (IC50);JAK | ||||||||||||||||||||
| 体外研究： | Solcitinib is an orally active, competitive, potent, selective JAK1 inhibitor, with an IC50 of 9.8 nM, and 11-, 55- and 23-fold selectivity over JAK2, JAK3 and TYK2, respectively. Solcitinib is used in the research of moderate-to-severe plaque-type psoriasis | ||||||||||||||||||||
| 参考文献： | 1. Ludbrook VJ, et al. Investigation of selective JAK1 inhibitor GSK2586184 for the treatment of psoriasis in a randomized placebo-controlled phase IIa study. Br J Dermatol. 2016 May;174(5):985-95. | ||||||||||||||||||||
| 溶解性： | soluble in DMSO | ||||||||||||||||||||
| 保存条件： | -20℃ | ||||||||||||||||||||
| 配置溶液浓度参考： |
|
||||||||||||||||||||
| 注意： | 部分产品我司仅能提供部分信息，我司不保证所提供信息的权威性，仅供客户参考交流研究之用。 |
上海工商
沪公网安备 31011702002021号
危险品化学品经营许可证（不带存储）
营业执照(三证合一)
北京